Results 11 to 20 of about 22,128 (232)

Prevalence and risk factors of Vernal Keratoconjunctivitis among a Ghanaian clinical cohort: A case-control study. [PDF]

Health Sci Rep
Abstract Background Vernal Keratoconjunctivitis (VKC) has been determined to be highly prevalent in countries within the tropical climate region. However, little evidence from studies conducted within this region has been put forward to support this claim.
Kyei S, Nkansah M, Asiedu K, Asiamah R, Zaabaar E, Afrifa-Yamoah E.   +5 more
europepmc   +3 more sources

Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2023
Introduction: Vernal keratoconjunctivitis is a seasonally recurring, bilateral inflammation of the conjunctiva, that occurs in male children with invariable personal or family history of atopy.
Neha Priyadarshani Chaudhary, Badri Prasad Badhu, Prabhat Deo   +2 more
doaj   +2 more sources

Vernal Keratoconjunctivitis

Journal of the Foundations of Ophthalmology
Kaur K, Gurnani B.
europepmc   +3 more sources

Unraveling the complexity – Insights and interventions of refractory vernal keratoconjunctivitis [PDF]

The ocular surface
Vernal keratoconjunctivitis (VKC) is a chronic severe ocular allergic inflammation mostly observed in children and young adults. The ocular manifestations are the expression of multifactorial immune mechanisms that generally have a good prognosis ...
Andrea Leonardi, Bhaskar Srinivasan, Geetha Iyer, Serge Doan, Shweta Agarwal   +4 more
core   +2 more sources

The psychological impact of vernal keratoconjunctivitis on families: An investigation on quality of life and psychological wellbeing. [PDF]

Pediatr Allergy Immunol
Abstract Background Vernal keratoconjunctivitis (VKC) is a chronic allergic eye disease that affects children and adolescents. While its physical burden is well documented, little research has explored its psychological impact on patients and their families.
Natali L, Cardi V, Cavarzeran F, Leonardi A.   +3 more
europepmc   +2 more sources

Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response Prediction. [PDF]

Allergy
Allergy, Volume 80, Issue 7, Page 2050-2054, July 2025.
Bilotta MT, Vacca P, Esposito M, Buzzonetti L, Bianco G, Fiocchi AG, Moretta L, Raponi M, Artesani MC, Tumino N.   +9 more
europepmc   +2 more sources

Ocular Manifestations in Children with Vernal Keratoconjunctivitis. [PDF]

Children (Basel)
Background: Vernal keratoconjunctivitis (VKC) is a chronic, recurrent, and frequently severe allergic ocular condition predominantly impacting children and adolescents in tropical and subtropical areas.
Capobianco M, Zeppieri M, Gagliano G, Visalli F, D'Esposito F, Foti R, Cannizzaro L, Tognetto D, Gagliano C.   +8 more
europepmc   +2 more sources

Vernal keratoconjunctivitis in human immunodeficiency positives: A case series. [PDF]

Indian J Ophthalmol
Purpose: To analyze the clinical profile of vernal keratoconjunctivitis (VKC) and its response to treatment in human immunodeficiency virus (HIV) patients and its relation with CD4 counts.
Agarwal S, Srinivasan B, Iyer G, Patel N, Rajagopal R, Gurumurthy S, Sudharshan S.   +6 more
europepmc   +2 more sources

Tear film parameters and meibography in eyes of children with vernal keratoconjunctivitis. [PDF]

Indian J Ophthalmol
Purpose: To study tear film parameters and Meibomian glands in pediatric patients with vernal keratoconjunctivitis (VKC). Methods: Forty-four eyes of 22 patients with VKC and 44 eyes of 22 age-matched controls were studied in a hospital-based cross ...
Gupta R, Arora R, Gupta I, Jain P.
europepmc   +2 more sources

Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators. [PDF]

Life (Basel)
Vernal keratoconjunctivitis (VKC) is a complex and multifactorial disease process that employs Th2 cell-mediated immunologic processes, which involves the overexpression of interleukin 4 (IL-4), IL-5, IL-9, IL-13, and IL-31, and the activation of mast ...
Hehar NK, Chigbu DI.
europepmc   +2 more sources